1. Home
  2. BMHL vs GOSS Comparison

BMHL vs GOSS Comparison

Compare BMHL & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BMHL

Bluemount Holdings Limited Class B Ordinary Shares

N/A

Current Price

$3.33

Market Cap

93.9M

Sector

N/A

ML Signal

N/A

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.35

Market Cap

101.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMHL
GOSS
Founded
2016
2015
Country
Hong Kong
United States
Employees
9
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.9M
101.2M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BMHL
GOSS
Price
$3.33
$0.35
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$4.19
AVG Volume (30 Days)
1.6K
14.1M
Earning Date
08-14-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$48,471,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$147.82
P/E Ratio
$66.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.72
$0.32
52 Week High
$4.48
$3.87

Technical Indicators

Market Signals
Indicator
BMHL
GOSS
Relative Strength Index (RSI) 46.53 24.12
Support Level $3.32 $0.33
Resistance Level $3.89 $0.60
Average True Range (ATR) 0.16 0.04
MACD -0.01 0.06
Stochastic Oscillator 50.00 14.09

Price Performance

Historical Comparison
BMHL
GOSS

About BMHL Bluemount Holdings Limited Class B Ordinary Shares

Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: